CHRONIC MYELOMONOCYTIC LEUKAEMIA

This adverse event was reported 660 times

CHRONIC MYELOMONOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEDAZURIDINE AND DECITABINE 3 0.0031
1 AZACITIDINE 90 0.0030
2 DECITABINE 11 0.0025
3 IBRITUMOMAB TIUXETAN 3 0.0020
4 LOMUSTINE 5 0.0019
5 AMOXICILLIN AND CLAVULANATE POTASSIUM 7 0.0015
6 MITOXANTRONE HYDROCHLORIDE 9 0.0014
7 ROMIPLOSTIM 21 0.0014
8 TAMOXIFEN CITRATE 7 0.0012
9 HYDROXYUREA 24 0.0011
See all drugs enriched for association with CHRONIC MYELOMONOCYTIC LEUKAEMIA

CHRONIC MYELOMONOCYTIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Macrolide Antibacterial [EPC] 2 0.0020
1 Thrombopoietin Receptor Agonist [EPC] 21 0.0014
2 Actinomycin [EPC] 2 0.0009
3 CD38-directed Cytolytic Antibody [EPC] 5 0.0009
4 Sulfone [EPC] 7 0.0006
5 Pyrethroid [EPC] 1 0.0006
6 CD33-directed Immunoconjugate [EPC] 2 0.0005
7 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
8 Nucleoside Metabolic Inhibitor [EPC] 131 0.0005
9 Provitamin D2 Compound [EPC] 14 0.0005
See all drug classes enriched for association with CHRONIC MYELOMONOCYTIC LEUKAEMIA